The MassARRAY® technology has been used in genetic research settings for almost 20 years and has been featured in over 4,000 peer-reviewed publications globally. It brings a proven level of technological performance for molecular analysis.
Featured Publications
Liquid Biopsy ,
Predicting response to neoadjuvant chemotherapy with liquid biopsies and multiparametric MRI in patients with breast cancer
npj Breast Cancer 2024
Infectious Disease ,
A comparative study of MassARRAY and GeneXpert assay in detecting rifampicin resistance in tuberculosis patients’ clinical specimens
Frontiers in microbiology 2024
Methylation ,
Prediction of outcomes for high-count monoclonal B lymphocytosis using an epigenetic and immunogenetic signature
Blood 2024
PGx ,
Haplotype phasing of CYP2D6: an allelic ratio method using Agena MassARRAY data
Translational Psychiatry 2023
Liquid Biopsy ,
The emergence of RAS mutations in patients with RAS wild-type mCRC receiving cetuximab as first-line treatment: a noninterventional, uncontrolled multicenter study
British Journal of Cancer 2023
Sample Integrity ,
Detection and Correction of Sample Misidentifications in a Biobank Using the MassARRAY System and Genomic Information